The Nutritional Outlook Podcast Episode 9: What does new FDA leadership mean for the dietary supplement industry?
In this episode, the Nutritional Outlook editors interview Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP’s FDA and Healthcare practices. Previously, Durkin worked as the acting director and deputy director of the Office of Dietary Supplement Programs, in the FDA’s Center for Food Safety and Applied Nutrition. Given Durkin’s experience at FDA, he is well-qualified to provide some insights into how the leadership of FDA’s recently confirmed commissioner Robert Califf, MD, may affect the dietary supplement industry.
Robert Durkin, Of Counsel, for Arnall Golden Gregory LLP.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
November 15th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.
The Nutritional Outlook Podcast Episode 35: Prioritizing Women's Health Research and Innovation
October 28th 2024On this month's episode of the Nutritional Outlook Podcast, Cepham's founder and president, Anand Swaroop, discusses the company's recent announcement to prioritize women's health research and innovation.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
